Evidence map›Paper›PMID 40131364›Full record

ArticleJCI insight2025

SEC24C deficiency causes trafficking and glycosylation abnormalities in an epileptic encephalopathy with cataracts and dyserythropoeisis.

Nina Bögershausen, Büsranur Cavdarli, Taylor H Nagai, Miroslav P Milev, Alexander Wolff, Mahsa Mehranfar, Julia Schmidt, Dharmendra Choudhary, Óscar Gutiérrez-Gutiérrez, Lukas Cyganek and 15 more

Abstract read
In one paragraph

Article in JCI insight, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. A Report of a Child with SEC31A-Related Neurodevelopmental Disorder.International journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Nina BögershausenInstitute of Human Genetics, University Medical Center Göttingen, Göttingen, Germany.
Büsranur CavdarliDepartment of Medical Genetics, Ankara Bilkent City Hospital, Ankara, Turkey.
Taylor H NagaiVanderbilt Genetics Institute and Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Miroslav P MilevDepartment of Biology, Concordia University, Montréal, Québec, Canada.
Alexander WolffInstitute of Human Genetics, University Medical Center Göttingen, Göttingen, Germany.
Mahsa MehranfarDepartment of Chemistry and Biochemistry, Concordia University, Montréal, Québec, Canada.
Julia SchmidtInstitute of Human Genetics, University Medical Center Göttingen, Göttingen, Germany.
Dharmendra ChoudharyVanderbilt Genetics Institute and Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Óscar Gutiérrez-GutiérrezStem Cell Unit, Department of Cardiology and Pneumology, University Medical Center Göttingen, Göttingen, Germany.
Lukas CyganekStem Cell Unit, Department of Cardiology and Pneumology, University Medical Center Göttingen, Göttingen, Germany.
Djenann Saint-DicDepartment of Biology, Concordia University, Montréal, Québec, Canada.
Arne ZibatInstitute of Human Genetics, University Medical Center Göttingen, Göttingen, Germany.
Karl KöhrerGenomics & Transcriptomics Laboratory, Biological and Medical Research Center (BMFZ), and.
Tassilo E WollenweberGenomics & Transcriptomics Laboratory, Biological and Medical Research Center (BMFZ), and.
Dagmar WieczorekInstitute of Human Genetics, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany.
Janine AltmüllerBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
Tatiana BorodinaBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
Dilek KaçarDepartment of Pediatric Hematology, Ankara Bilkent City Hospital, Ankara, Turkey.
Göknur HaliloğluDivision of Pediatric Neurology, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Yun LiInstitute of Human Genetics, University Medical Center Göttingen, Göttingen, Germany.
Christian ThielCenter for Pediatric and Adolescent Medicine, Department I, Heidelberg University, Heidelberg, Germany.
Michael SacherDepartment of Biology, Concordia University, Montréal, Québec, Canada.
Ela W KnapikVanderbilt Genetics Institute and Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Gökhan YigitInstitute of Human Genetics, University Medical Center Göttingen, Göttingen, Germany.
Bernd WollnikInstitute of Human Genetics, University Medical Center Göttingen, Göttingen, Germany.

Funding

Discovering Biology for Neuropsychiatric Diseases Through Omics Studies on ComorbiditiesR01MH113362 · NIMH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI COX, NANCY J, KNAPIK, ELA W · 2017 to 2021
$3.9M
Advancing drug repositioning and development for Alzheimer's Disease using functional genomics and computational phenomicsR56AG068026 · NIA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GAMAZON, ERIC R · 2021 to 2022
$1.5M
NIA NIH HHS R56 AG068026NIMH NIH HHS R01 MH113362
6 · The paper itself

Abstract

As a major component of intracellular trafficking, the coat protein complex II (COPII) is indispensable for cellular function during embryonic development and throughout life. The 4 SEC24 proteins (A-D) are essential COPII components involved in cargo selection and packaging. A human disorder corresponding to alterations of SEC24 function is currently known only for SEC24D. Here, we reported that biallelic loss of SEC24C leads to a syndrome characterized by primary microcephaly, brain anomalies, epilepsy, hearing loss, liver dysfunction, anemia, and cataracts in an extended consanguineous family with 4 affected individuals. We showed that knockout of sec24C in zebrafish recapitulated important aspects of the human phenotype. SEC24C-deficient fibroblasts displayed alterations in the expression of several COPII components as well as impaired anterograde trafficking to the Golgi, indicating a severe impact on COPII function. Transcriptome analysis revealed that SEC24C deficiency also affected the proteasome and autophagy pathways. Moreover, a shift in the N-glycosylation pattern and deregulation of the N-glycosylation pathway suggested a possible secondary alteration of protein glycosylation, linking the described disorder with the congenital disorders of glycosylation.

Indexed as

CataractEpilepsyVesicular Transport ProteinsAnimalsAnimals, Genetically ModifiedGlycosylationGolgi ApparatusHumansMicrocephalyPedigreeProtein TransportZebrafishVesicular Transport ProteinsEpilepsyGeneticsGlycobiologyNeuroscienceProtein traffic

Identifiers

PMID40131364
PMCPMC12128993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.